Search Results

The Role of the Endocannabinoid System in the Regulation of Hypothalamic-Pituitary-Adrenal Axis Activity

Author: Cota, D.

Source: Journal of Neuroendocrinology, Volume 20, Supplement 1, May 2008 , pp. 35-38(4)

Publisher: Blackwell Publishing

Therapeutic Potential of the Endocannabinoid System in the Brain

Authors: Ramos, Jose A.; Gonzalez, Sara; Sagredo, Onintza; Gomez-Ruiz, Maria; Fernandez-Ruiz, Javier

Source: Mini Reviews in Medicinal Chemistry, Volume 5, Number 7, July 2005 , pp. 609-617(9)

Publisher: Bentham Science Publishers

Involvement of the Endocannabinoid System in Motor Disorders

Authors: J. J. Fernandez-Ruiz; I. Lastres-Becker; A. Cabranes; E. de Lago; J. A. Ramos

Source: Current Medicinal Chemistry - Central Nervous System Agents, Volume 4, Number 3, September 2004 , pp. 175-182(8)

Publisher: Bentham Science Publishers

Cannabinoids as Analgesic Agents: Evidence from In Vivo Studies

Authors: Finn D. P.; Chapman V.

Source: Current Neuropharmacology, Volume 2, Number 1, January 2004 , pp. 75-89(15)

Publisher: Bentham Science Publishers

Cannabinoid Function in Spatial Learning: An Update

Authors: Robinson L.; Riedel G.

Source: Current Neuropharmacology, Volume 2, Number 1, January 2004 , pp. 125-143(19)

Publisher: Bentham Science Publishers

The Endocannabinoid System and Huntington's Disease

Authors: Lastres-Becker I.; Miguel R.D.; Fernandez-Ruiz J.J.

Source: Current Drug Targets-CNS & Neurological Disorders, Volume 2, Number 5, October 2003 , pp. 335-347(13)

Publisher: Bentham Science Publishers

Milk intake and survival in newborn cannabinoid CB₁ receptor knockout mice: evidence for a ''CB₃'' receptor

Authors: Fride E.; Foox A.; Rosenberg E.; Faigenboim M.; Cohen V.; Barda L.; Blau H.; Mechoulam R.

Source: European Journal of Pharmacology, Volume 461, Number 1, 7 February 2003 , pp. 27-34(8)

Publisher: Elsevier

Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents - Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects

Author: Fowler C.J.

Source: Brain Research Reviews, Volume 41, Number 1, January 2003 , pp. 26-43(18)

Publisher: Elsevier

The endogenous cannabinoid system and the basal ganglia - biochemical, pharmacological, and therapeutic aspects

Authors: Romero J.; Lastres-Becker I.; de Miguel R.; Berrendero¹ F.; Ramos J.A.; Fernandez-Ruiz J.

Source: Pharmacology and Therapeutics, Volume 95, Number 2, August 2002 , pp. 137-152(16)

Publisher: Elsevier

Cannabinoids and pain relief

Authors: Holdcroft, Anita; Patel, Parind

Source: Expert Review of Neurotherapeutics, Volume 1, Number 1, September 2001 , pp. 92-99(8)

Publisher: Expert Reviews

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ⁹-Tetrahydrocannabinol-Tolerant Rats

Authors: Di Marzo, V.; Berrendero, F.; Bisogno, T.; González, S.; Cavaliere, P.; Romero, J.; Cebeira, M.; Ramos, J. A.; Fernández-Ruiz, J. J.

Source: Journal of Neurochemistry, Volume 74, Number 4, April 2000 , pp. 1627-1635(9)

Publisher: Blackwell Publishing

Role of endocannabinoids in brain development

Authors: Fernandez-Ruiz J.J.; Berrendero F.; Hernandez M.L.; Romero J.; Ramos J.A.

Source: Life Sciences, Volume 65, Number 6, 1999 , pp. 725-736(12)

Publisher: Elsevier